Cancer Research Audrey Hepburn Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramovitch, R.
Right arrow Articles by Honigman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramovitch, R.
Right arrow Articles by Honigman, A.
[Cancer Research 64, 1338-1346, February 15, 2004]
© 2004 American Association for Cancer Research

Regular Articles

A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression

Rinat Abramovitch1,2, Einat Tavor3, Jasmine Jacob-Hirsch5, Evelyne Zeira1, Ninette Amariglio5, Orit Pappo4, Gideon Rechavi5,6, Eithan Galun1 and Alik Honigman3

1 Goldyne Savad Institute of Gene Therapy,2 MRI/MRS Lab, HBRC,3 Department of Virology, and4 Department of Pathology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel, and5 Department of Pediatric Hemato-Oncology, Safra Children’s Hospital, Sheba Medical Center and6 Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Tumor microenvironment controls the selection of malignant cells capable of surviving in stressful and hypoxic conditions. The transcription factor, cyclic AMP-responsive element binding (CREB) protein, activated by multiple extracellular signals, modulates cellular response by regulating the expression of a multitude of genes. Previously, we have demonstrated that two cystein residues, at the DNA binding domain of CREB, mediate activation of CREB-dependent gene expression at normoxia and hypoxia. The construction of a dominant-positive CREB mutant, insensitive to hypoxia cue (substitution of two cystein residues at position 300 and 310 with serine in the DNA binding domain) and of a dominant negative CREB mutant (addition of a mutation in serine133), enabled a direct assessment, in vitro and in vivo, of the role of CREB in tumor progression. In this work, we demonstrate both in vitro and in vivo that CREB controls hepatocellular carcinoma growth, supports angiogenesis, and renders resistance to apoptosis. Along with the identification, by DNA microarray, of the CREB-regulated genes in normoxia and hypoxia, this work demonstrates for the first time that in parallel to other hypoxia responsive mechanisms, CREB plays an important role in hepatocellular carcinoma tumor progression.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Genua, G. Pandini, D. Sisci, G. Castoria, M. Maggiolini, R. Vigneri, and A. Belfiore
Role of Cyclic AMP Response Element-Binding Protein in Insulin-like Growth Factor-I Receptor Up-regulation by Sex Steroids in Prostate Cancer Cells
Cancer Res., September 15, 2009; 69(18): 7270 - 7277.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J. Rozenberg, V. Rishi, A. Orosz, J. Moitra, A. Glick, and C. Vinson
Inhibition of CREB Function in Mouse Epidermis Reduces Papilloma Formation
Mol. Cancer Res., May 1, 2009; 7(5): 654 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
H. Sun, W.-C. Chung, S.-H. Ryu, Z. Ju, H. T. Tran, E. Kim, J. M. Kurie, and J. S. Koo
Cyclic AMP-Responsive Element Binding Protein- and Nuclear Factor-{kappa}B-Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis
Cancer Prevention Research, October 1, 2008; 1(5): 316 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
R. Meyuhas, E. Pikarsky, E. Tavor, A. Klar, R. Abramovitch, J. Hochman, T. G. Lago, and A. Honigman
A Key Role for Cyclic AMP-Responsive Element Binding Protein in Hypoxia-Mediated Activation of the Angiogenesis Factor CCN1 (CYR61) in Tumor Cells
Mol. Cancer Res., September 1, 2008; 6(9): 1397 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. M. Ansari, Y. M. Sung, G. He, and S. M. Fischer
Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin
Carcinogenesis, October 1, 2007; 28(10): 2063 - 2068.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. A. Lang, D. Klein, C. Moser, A. Gaumann, G. Glockzin, M. H. Dahlke, W. Dietmaier, U. Bolder, H. J. Schlitt, E. K. Geissler, et al.
Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo
Mol. Cancer Ther., March 1, 2007; 6(3): 1123 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Cougot, Y. Wu, S. Cairo, J. Caramel, C.-A. Renard, L. Levy, M. A. Buendia, and C. Neuveut
The Hepatitis B Virus X Protein Functionally Interacts with CREB-binding Protein/p300 in the Regulation of CREB-mediated Transcription
J. Biol. Chem., February 16, 2007; 282(7): 4277 - 4287.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Nomura, W.-C. Huang, H. E. Zhau, D. Wu, Z. Xie, H. Mimata, M. Zayzafoon, A. N. Young, F. F. Marshall, M. N. Weitzmann, et al.
{beta}2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP-Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor Axis
Clin. Cancer Res., December 15, 2006; 12(24): 7294 - 7305.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
O Gubbay, M T Rae, A S McNeilly, F X Donadeu, A J Zeleznik, and S G Hillier
cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival.
J. Endocrinol., October 1, 2006; 191(1): 275 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-C. Huang, D. Wu, Z. Xie, H. E. Zhau, T. Nomura, M. Zayzafoon, J. Pohl, C.-L. Hsieh, M. N. Weitzmann, M. C. Farach-Carson, et al.
{beta}2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis.
Cancer Res., September 15, 2006; 66(18): 9108 - 9116.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
N. Dronadula, F. Rizvi, E. Blaskova, Q. Li, and G. N. Rao
Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility
J. Lipid Res., April 1, 2006; 47(4): 767 - 777.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Ziemann, A. Riecke, G. Rudell, E. Oetjen, H. J. Steinfelder, C. Lass, G. F. Kahl, and K. I. Hirsch-Ernst
The Role of Prostaglandin E Receptor-Dependent Signaling via cAMP in Mdr1b Gene Activation in Primary Rat Hepatocyte Cultures
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 378 - 386.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Stepulak, M. Sifringer, W. Rzeski, S. Endesfelder, A. Gratopp, E. E. Pohl, P. Bittigau, U. Felderhoff-Mueser, A. M. Kaindl, C. Buhrer, et al.
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth
PNAS, October 25, 2005; 102(43): 15605 - 15610.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.